Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N07XX13
|
| gptkbp:CASNumber |
89-25-8
|
| gptkbp:chemicalFormula |
C10H10N4O
|
| gptkbp:countryOfOperation |
gptkb:Japan
gptkb:United_States |
| gptkbp:form |
oral suspension
solution for infusion |
| gptkbp:genericName |
gptkb:edaravone
|
| https://www.w3.org/2000/01/rdf-schema#label |
Radicava
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Mitsubishi_Tanabe_Pharma
|
| gptkbp:mechanismOfAction |
free radical scavenger
|
| gptkbp:pregnancyCategory |
not assigned
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
headache
allergic reactions gait disturbance bruising |
| gptkbp:synonym |
gptkb:MCI-186
|
| gptkbp:usedFor |
amyotrophic lateral sclerosis
|
| gptkbp:bfsParent |
gptkb:edaravone
|
| gptkbp:bfsLayer |
5
|